Mylan's Rs 5,168-cr proposal to acquire Agila cleared

New Delhi: The Foreign Investment Promotion Board (FIPB) has cleared US-based pharmaceutical firm Mylan Inc's Rs 5,168 crore proposal to acquire Indian generic drugs company Agila Specialties.The proposal will now have to be approved by
mylan s rs 5 168 cr proposal to acquire agila...
India TV Business Desk 28 Aug 2013, 10:04 AM IST
New Delhi: The Foreign Investment Promotion Board (FIPB) has cleared US-based pharmaceutical firm Mylan Inc's Rs 5,168 crore proposal to acquire Indian generic drugs company Agila Specialties.



The proposal will now have to be approved by the Cabinet Committee on Economic Affairs (CCEA), as it involves investments of more than Rs 1,200 crore.

The Department of Industrial Policy & Promotion (DIPP) had earlier objected to the takeover on the grounds that it could affect the availability of oncology (cancer-related) injectables, which are produced by just a couple of Indian drug-makers.
Related Tags: Mylan Inc
 
 
 

Write a comment

 

More from business